Aug 2026· Frontiers in Cell and Developmental Biology· Vol 14· 0 citations· 112 references
Medicine
TL;DR
A multiscale framework that spans from molecular mechanisms to organ-level physiology and focuses on the directly mechanosensitive Piezo1/2 channels and the mechano-responsive TRPV4 channel is developed, drawing on their distinct molecular architectures to ground divergent gating properties.
Abstract
Soft tissue fibrosis and chronic pain involve a cycle linking extracellular matrix (ECM) stiffening, inflammation, and neural sensitization. This review develops a multiscale framework that spans from molecular mechanisms to organ-level physiology and focuses on the directly mechanosensitive Piezo1/2 channels and the mechano-responsive TRPV4 channel, drawing on their distinct molecular architectures to ground divergent gating properties. We examine how these channels convert membrane tension and integrin-mediated traction into Ca2+ and other ionic signals that, together with Ca2+-independent pathways engage YAP/TAZ, NF-κB, and TGF-β pathways, thereby reshaping transcriptional programs. We then conceptualize healthy ECM as a “spatial filter,” noting that viscoelasticity and non-affine fiber rearrangements buffer superficial loads, whereas fibrotic cross-linking erodes this protection, chronically exposing fibroblasts and sensory endings to elevated mechanical and inflammatory cues. This may drive pathological “stiffness–inflammation–fibrosis/pain” loops. Finally, we propose a mechanical therapeutic window in which mechanical interventions, parameterized by channel modulation and/or viscoelastic biomaterials, reset the local environment toward a near-physiological state. Within this Goldilocks zone, reparative and inflammation-resolving pathways can be preferentially engaged while minimizing damage and pain amplification. This integrated perspective offers a conceptual framework for understanding fibrosis-associated disorders and chronic soft-tissue pain, and may inform therapies targeting Piezo/TRPV4 signaling and ECM viscoelasticity.
Piezo1 is an important mechanosensitive regulator linking mechanical cues to musculoskeletal biology, although its tissue-specific roles, interactions with other mechanosensitive channels, and clinical translational value require further study.
Hong Zhao, Jun-Yang Huang, Ya-Yi Tan et al.· Bone Reports· 0 citations
Aging tissues paradoxically stiffen while losing mechanical resilience, becoming fragile, poorly regenerative and chronically inflamed. We review evidence that these phenotypes emerge from progressive failure of mechanotransduction across a mechanically integrated axis linking extracellular matrix (ECM) architecture, i...
Anastasia Zhurikhina, Maia Kirkegaard, Alberto Guarnieri et al.· Journal of Cell Science· 0 citations
Multiorgan fibrosis is a complex, maladaptive response to chronic injury, where the extracellular matrix (ECM) shifts from serving merely as a structural framework to becoming an active, sustained contributor to disease progression. We propose a unifying mechanobiological framework in which chronic injury promotes fibr...
A. Lonardo, Ralf Weiskirchen· Journal of cell communicatio...· 0 citations
Osteoarthritis (OA) is the most prevalent degenerative joint disease worldwide, affecting approximately 250 million individuals. Mechanical imbalance serves as both its primary driving force and pathological hallmark. Mechanobiology-based interventions remain constrained by an insufficient understanding of how chondroc...
Zi-Qi Gao, Yu-Le Zheng, Hong-Xiang Mei et al.· Mechanobiology in medicine· 0 citations
OBJECTIVE
Human skin is a highly dynamic organ capable of sensing and responding to mechanical stimuli through tightly regulated communication between the epidermis and dermis. Daily mechanical forces-such as stretching and compression-modulate skin structure and function via mechanotransduction pathways. Central to th...
J. Chlasta, G. Runel, Manon Boussard et al.· International Journal of Cos...· 0 citations
Cutaneous scarring remains a major clinical challenge, often resulting in impaired function, altered tissue mechanics, and poor aesthetic outcomes. Most current anti-fibrotic therapies target late-stage fibrosis, when extracellular matrix deposition and myofibroblast persistence are already established, limiting regene...
R. S. Hamad, Mohamed A. M. Ali, A. Chaudhary et al.· Wound Repair and Regeneratio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.